Larry Mathis Financial Planning’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Larry Mathis Financial Planning's BMY Position: Q3 2026 in Review
Larry Mathis Financial Planning reduced its Bristol-Myers Squibb (BMY) stake by 4.6% in Q3 2026, selling an estimated $25.6K and leaving 8,492 shares worth $530K. The position accounts for 0.45% of the portfolio, ranked #46.
Larry Mathis Financial Planning first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Larry Mathis Financial Planning held 8,492 shares of Bristol-Myers Squibb worth $530K as of Q3 2026.
- Larry Mathis Financial Planning sold 405 Bristol-Myers Squibb shares in Q3 2026, an estimated $25.6K.
- Bristol-Myers Squibb made up 0.45% of Larry Mathis Financial Planning's portfolio in Q3 2026, its #46 holding.
- Larry Mathis Financial Planning first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Larry Mathis Financial Planning's 13F filing for Q3 2026, filed 26 Oct 2026.